The most frequent mutations in the ABL sgRNA_2 CML cell pool were 1-bp insertions (27.7%) and other mutations (1.9%) (Figure 5K). The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.